The system will be going down for regular maintenance. Please save your work and logout.
Effectiveness and safety of standard and reduced doses of dabigatran versus rivaroxaban in non-valvular atrial fibrillation: A cohort study in the snds french nationwide claims database
Language
EN
Article de revue
This item was published in
Value Health. 2018-10, vol. 21, p. S7-S7
English Keywords
PharmacoEpi-Drugs
CIC1401